Tidewater Office Partners (TWOP) — Second-Priority Term Loan
Executive Summary
Demo purchase of $100M face of Second-Priority Term Loan at 72.0 (cash investment $72.4M): current yield 11.9%, yield to maturity 26.8%. Recommendation: PASS. Credit score 32/100 (High risk). Base-case IRR 24.9%, downside -10.5%, severe -84.0%; probability-weighted IRR 5.8% vs a 12% hurdle; weighted P(default) 100%; severe-case valuation recovery 0%. PASS: Expected-cash-flow IRR (probability-weighted) clears hurdle; Downside IRR stays above floor; Downside recovery meets minimum (valuation waterfall). The return does not compensate for the modelled downside.
Investment Thesis
Appraised value covers the mortgage and most of the second-priority loan today, but the November 2026 unsecured maturity and March 2027 CMBS maturity compress the timeline. Returns are asymmetric: strong in base/downside, near-total loss in severe where office values fall >35%.
The question: Does a 26.8% yield on a rank-2 secured claim compensate for 100% probability-weighted default risk and 100% severe-case loss?
Company Overview
Class-B downtown office portfolio (28 buildings, 82% leased) with a concentrated 2027 CMBS maturity. HQ Chicago, IL; Real Estate / Office REIT. FY2025A revenue $340M, EBITDA $195M (57.5% margin); total debt $1.8B, cash $70M. DEMO DATA
Industry / Market
Commercial real estate (office) is in a prolonged repricing; lenders at the top of the stack are protected by LTV but secondary-position capital is highly exposed to value declines.
Historical Financial Performance
| $M | FY2022A | FY2023A | FY2024A | FY2025A |
|---|---|---|---|---|
| Revenue | $385.0M | $370.0M | $355.0M | $340.0M |
| % growth | -3.9% | -4.1% | -4.2% | |
| Direct costs / COGS | $136.7M | $138.8M | $138.5M | $136.0M |
| Gross profit (NOI for real estate) | $248.3M | $231.3M | $216.5M | $204.0M |
| % margin | 64.5% | 62.5% | 61.0% | 60.0% |
| Operating expenses (cash, adjusted) | $9.6M | $9.3M | $8.9M | $8.5M |
| EBITDA (company-adjusted basis) | $238.7M | $222.0M | $207.7M | $195.5M |
| % margin | 62.0% | 60.0% | 58.5% | 57.5% |
| D&A | $92.4M | $88.8M | $85.2M | $81.6M |
| Share-based compensation | $0.0M | $0.0M | $0.0M | $0.0M |
| EBIT | $146.3M | $133.2M | $122.5M | $113.9M |
| Interest expense | $92.3M | $97.8M | $103.2M | $108.6M |
| EBT | $54.0M | $35.4M | $19.3M | $5.3M |
| Taxes | $13.5M | $8.9M | $4.8M | $1.3M |
| Net income (model basis) | $40.5M | $26.6M | $14.5M | $4.0M |
| Capex | $46.2M | $44.4M | $42.6M | $40.8M |
| Working capital & other cash items | ($0.4M) | ($0.8M) | ($0.8M) | ($0.8M) |
| Free cash flow | $87.1M | $71.7M | $57.8M | $45.5M |
Capital Structure
| Tranche | Rank | Secured | Face value | Rate | Maturity | Mark / price |
|---|---|---|---|---|---|---|
| Mortgage / CMBS | 1 | Yes | $1.1B | 5.85% | 2027-03-01 | 94.0 |
| Second-Priority Term Loan | 2 | Yes | $350.0M | S+435bp | 2028-06-30 | 72.0 |
| Unsecured Notes 4.5% | 3 | No | $250.0M | 4.50% | 2026-11-15 | 88.0 |
Total debt $1.8B (9.0x EBITDA); net debt $1.7B; liquidity $70M; loan-to-value through the target tranche 91%.
Credit Analysis
Net leverage 8.6x, EBITDA / interest 1.80x, FCF / debt 2.6%, DSCR 1.4x, liquidity ratio 0.2x. Score components: Leverage 0/15, Coverage 3/15, Liquidity 0/10, Free cash flow 3/10, Maturity risk 0/10, Margin stability 8/10, Revenue stability 8/8, Asset coverage 5/12, Industry risk 5/10. Score change vs FY2024A (same capital structure): 34 → 32 (Interest coverage fell from 2.0x to 1.8x (-0.8 pts, negative); FCF / debt fell from 3.3% to 2.6% (-0.5 pts, negative)).
Debt Maturity Profile
| Period | Debt due | % of debt | Projected liquidity (Base) | Refinancing requirement |
|---|---|---|---|---|
| FY2026E | $250M | 14% | $113M | $137M |
| FY2027E | $1.1B | 66% | $45M | $1.1B |
| FY2028E | $350M | 20% | $46M | $304M |
Risk flag: $1150M maturity in FY2027E; only $45M projected liquidity; $1105M refinancing requirement.
Risk flag: $350M maturity in FY2028E; only $46M projected liquidity; $304M refinancing requirement.
| Tranche | Matures | Balance at maturity | Cash on hand | Net lev. (test ≤) | Pro-forma coverage (test ≥) | Refi rate | Interest burden after | Result | Resolution |
|---|---|---|---|---|---|---|---|---|---|
| Unsecured Notes 4.5% | FY2026E | $250.0M | $70M | 8.8x (8.5x) | 1.63x (1.20x) | 8.0% | — | REFINANCING FAILURE | Partially repaid; payment default |
| Mortgage / CMBS | FY2027E | $1.1B | $0M | 8.7x (8.5x) | 1.48x (1.20x) | 8.0% | — | REFINANCING FAILURE | Partially repaid; payment default |
| Second-Priority Term Loan | FY2028E | $350.0M | $0M | 8.6x (8.5x) | 1.87x (1.20x) | 8.0% | — | REFINANCING FAILURE | Partially repaid; payment default |
Base Case
Revenue CAGR -2.0%; FY2030E EBITDA $179M (58.3% margin); trough EBITDA $179M; peak net leverage 8.5x; minimum EBITDA / interest 1.76x; cumulative FCF $225M. Payment default modelled in FY2026E; target-tranche recovery 100%. IRR 24.9%, MOIC 1.53x.
Downside Case
Revenue CAGR -3.0%; FY2030E EBITDA $162M (55.5% margin); trough EBITDA $162M; peak net leverage 9.8x; minimum EBITDA / interest 1.53x; cumulative FCF $121M. Payment default modelled in FY2026E; target-tranche recovery 48%. IRR -10.5%, MOIC 0.82x.
Severe Downside
Revenue CAGR -7.7%; FY2030E EBITDA $120M (52.5% margin); trough EBITDA $120M; peak net leverage 14.7x; minimum EBITDA / interest 1.04x; cumulative FCF ($76M). Payment default modelled in FY2026E; target-tranche recovery 0%. IRR -84.0%, MOIC 0.16x.
Covenant Analysis
| FY2026E | FY2027E | FY2028E | FY2029E | FY2030E | |
|---|---|---|---|---|---|
| Current metric | 8.55x | 8.45x | 8.35x | 8.23x | 8.12x |
| Covenant | ≤ 9.50x | ≤ 9.50x | ≤ 9.50x | ≤ 9.50x | ≤ 9.50x |
| Headroom | 0.95x (10%) | 1.05x (11%) | 1.15x (12%) | 1.27x (13%) | 1.38x (14%) |
| Status | PASS | PASS | PASS | PASS | PASS |
| FY2026E | FY2027E | FY2028E | FY2029E | FY2030E | |
|---|---|---|---|---|---|
| Current metric | 1.76x | 1.83x | 1.87x | 1.91x | 1.88x |
| Covenant | ≥ 1.50x | ≥ 1.50x | ≥ 1.50x | ≥ 1.50x | ≥ 1.50x |
| Headroom | 0.26x (18%) | 0.33x (22%) | 0.37x (25%) | 0.41x (27%) | 0.38x (25%) |
| Status | PASS | PASS | PASS | PASS | PASS |
| FY2026E | FY2027E | FY2028E | FY2029E | FY2030E | |
|---|---|---|---|---|---|
| Current metric | 9.48x | 9.85x | 9.71x | 9.66x | 9.62x |
| Covenant | ≤ 9.50x | ≤ 9.50x | ≤ 9.50x | ≤ 9.50x | ≤ 9.50x |
| Headroom | 0.02x (0%) | −0.35x (-4%) | −0.21x (-2%) | −0.16x (-2%) | −0.12x (-1%) |
| Status | PASS | BREACH | BREACH | BREACH | BREACH |
| FY2026E | FY2027E | FY2028E | FY2029E | FY2030E | |
|---|---|---|---|---|---|
| Current metric | 1.53x | 1.53x | 1.55x | 1.57x | 1.55x |
| Covenant | ≥ 1.50x | ≥ 1.50x | ≥ 1.50x | ≥ 1.50x | ≥ 1.50x |
| Headroom | 0.03x (2%) | 0.03x (2%) | 0.05x (4%) | 0.07x (5%) | 0.05x (4%) |
| Status | PASS | PASS | PASS | PASS | PASS |
Recovery Analysis
If the company defaults, recovery value is $1.1B (liquidation) in the severe case → 0% recovery (100% LGD) on the target tranche; downside 48%. Recovery value = MAX(going concern $913M, liquidation $1.1B) + cash, less administrative costs; severe case struck at FY2026E.
| Claim (by seniority) | Rank | Claim | Recovery | Recovery % | Loss | Loss % |
|---|---|---|---|---|---|---|
| Recovery value | $1.1B | |||||
| Less: administrative / DIP costs | ($42.6M) | |||||
| Mortgage / CMBS | 1 | $1.2B | $1.0B | 87.7% | $143.5M | 12.3% |
| Second-Priority Term Loan | 2 | $360.1M | $0.0M | 0.0% | $360.1M | 100.0% |
| Unsecured Notes 4.5% | 3 | $185.2M | $0.0M | 0.0% | $185.2M | 100.0% |
| Total claims | $1.7B | $1.0B | $688.8M | |||
| Equity (residual) | $0.0M | Wiped out | ||||
Investment Returns
| Base Case | Downside | Severe Downside | |
|---|---|---|---|
| Face value / purchase price / cash investment | $100M / 72.0 / $72.4M UNDERWRITING ASSUMPTION | ||
| Cash interest + exit/recovery proceeds | $8.6M + $102.2M | $10.1M + $49.0M | $11.6M + $0.0M |
| Capital gain / (loss) vs purchase price | $30.2M | ($23.0M) | ($72.0M) |
| MOIC | 1.53x | 0.82x | 0.16x |
| IRR (hurdle 12%) | 24.9% | -10.5% | -84.0% |
Key Risks
- Severe-case valuation recovery of 0% is below the 72.0 purchase price: a 100% loss given default.
- Thin interest coverage: EBITDA / interest 1.80x at FY2025A (EBITDA could fall 44% before coverage hits 1.0x).
- Refinancing: $1150M maturity in FY2027E; only $45M projected liquidity; $1105M refinancing requirement.
- Base-case refinancing fails for 3 maturing tranche(s).
- Downside-case recovery of 48% falls short of the purchase price.
Key Protections
- Secured, rank 2: $1.1B ranks ahead.
- Discounted second-priority entry at 72
- Asset sales to cure maturities
Catalysts
- Nov-2026 unsecured maturity
- Mar-2027 CMBS maturity / extension negotiation
- Disposition program
Due Diligence Items
| Item | Status | Priority | Open question |
|---|---|---|---|
| Historical financials tied to filings | In Progress | High | Do model inputs reconcile to audited statements? |
| Quality of earnings / EBITDA add-backs | In Progress | High | How much of adjusted EBITDA is add-backs? |
| Supplier concentration | Issue Identified | Low | Any single-source dependencies? |
| Competitive position and management | Not Started | Medium | Share trend and management track record? |
| Debt documentation review | Not Started | High | Priming / drop-down protections and baskets? |
| Covenant package and definitions | Not Started | High | Covenant EBITDA definition and headroom? |
| Maturity profile and refinancing plan | In Progress | High | Is the refinancing plan credible at current leverage? |
| Guarantees and structural subordination | Issue Identified | Medium | Which entities guarantee; any non-guarantor leakage? |
| Asset valuation / appraisal support | Not Started | High | Independent value vs assumed asset base? |
| Industry conditions and pricing | Not Started | Medium | Where are we in the industry cycle? |
| Macro and rate sensitivity | Not Started | Low | How does the credit behave at +300 bps? |
Recommendation
PASS. PASS: Expected-cash-flow IRR (probability-weighted) clears hurdle; Downside IRR stays above floor; Downside recovery meets minimum (valuation waterfall). The return does not compensate for the modelled downside.
| Test | Actual | Required | Weight | |
|---|---|---|---|---|
| ✓ | Base-case IRR clears hurdle | 24.9% | ≥ 12.0% | core |
| ✗ | Expected-cash-flow IRR (probability-weighted) clears hurdle | 5.8% | ≥ 12.0% | core |
| ✗ | Downside IRR stays above floor | -10.5% | ≥ 0.0% | core |
| ✗ | Downside recovery meets minimum (valuation waterfall) | 47.8% | ≥ 60.0% | core |
| ✗ | Base-case refinancing succeeds | FAILURE | PASS | core |
| ✓ | Entry yield meets minimum | 26.8% | ≥ 9.0% | secondary |
| ✗ | Net leverage within maximum | 8.6x | ≤ 6.0x | secondary |
| ✗ | Covenant headroom (base case, minimum) | 10.0% | ≥ 15.0% | secondary |
| ✗ | Principal protected in severe case (recovery ≥ price) | 0 vs 72.0 | recovery ≥ price | secondary |
| ✗ | No unresolved high-priority diligence | 6 open | 0 open | secondary |
What would change my mind?
- EBITDA declines more than 44% from FY2025A (coverage < 1.0x) — or more than 10% (first covenant breaks).
- The entry price is above 88.7: the base case no longer earns the 12% hurdle (assumed price 72.0).
- Severe-case recovery returns the purchase price only if the distressed valuation multiple is at least 10.6x EBITDA (the severe case assumes 6.5x); the question is how much cushion we want.
- Collateral / enterprise value falls more than 5% from the base-case valuation: the tranche starts to take losses.
- Market access weakens: base-case pro-forma coverage at refinancing is 1.63x vs the 1.20x test, at an assumed 8.0% refinancing rate — a higher spread or lower EBITDA flips the test.
Sources (3)
| Source | Document | Data type | Period | Accession | Doc date | Retrieved | Class |
|---|---|---|---|---|---|---|---|
| CreditIQ demo dataset | Tidewater Office Partners — illustrative financial statements FY2022–FY2025 | Income statement / cash flow | FY2022–FY2025 | — | 2026-03-31 | 2026-03-31 | DEMO DATA |
| CreditIQ demo dataset | Tidewater Office Partners — illustrative capital structure & covenants | Debt schedule | As of 2026-03-31 | — | 2026-03-31 | 2026-03-31 | DEMO DATA |
| CreditIQ demo dataset | Illustrative indicative bid marks (% of par) | Market price | 2026-03-31 | — | 2026-03-31 | 2026-03-31 | DEMO DATA |
Generated entirely from the structured model (inputs → analysis → memo): every figure reconciles to the Excel workbook (see Settings → Reconciliation). Hypothetical terms are underwriting assumptions. Not investment advice.